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A B S T R A C T
Background
Endophthalmitis is a severe inflammation of the anterior or posterior (or both) chambers of the eye that may be sterile or associated
with infection. It is a potentially vision-threatening complication of cataract surgery. Prophylactic measures for endophthalmitis are
targeted against various sources of infection.
Objectives
To evaluate the effects of perioperative antibiotic prophylaxis for endophthalmitis following cataract surgery compared with no pro-
phylaxis or other form of prophylaxis.
Search methods
We searched CENTRAL (which contains the Cochrane Eyes and Vision Trials Register) (2016, Issue 12), Ovid MEDLINE, Epub
Ahead of Print, In-Process & Other Non-Indexed Citations, Ovid MEDLINE Daily (January 1946 to December 2016), Embase
(January 1980 to December 2016), Latin American and Caribbean Health Sciences Literature Database (LILACS) (1982 to December
2016),the ISRCTN registry (www.isrctn.com/editAdvancedSearch), ClinicalTrials.gov (www.clinicaltrials.gov), and the World Health
Organization (WHO) International Clinical Trials Registry Platform (ICTRP) (www.who.int/ictrp/search/en). We used no date or
language restrictions in the electronic searches for trials. We last searched the electronic databases on 6December 2016. We also searched
for additional studies that cited any included trials using the Science Citation Index.
Selection criteria
We included randomized controlled trials that enrolled adults undergoing cataract surgery (any method and incision type) for lens
opacities due to any origin. We included trials that evaluated preoperative antibiotics, intraoperative (intracameral, subconjunctival or
systemic), or postoperative antibiotic prophylaxis for acute endophthalmitis. We excluded studies that evaluated antiseptic preoperative
preparations using agents such as povidone iodine or antibiotics for treating acute endophthalmitis after cataract surgery.
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Data collection and analysis
Two review authors independently reviewed abstracts and full-text articles for eligibility, assessed the risk of bias for each included study,
and abstracted data.
Main results
Five studies met the inclusion criteria for this review, including 101,005 adults and 132 endophthalmitis cases. While the sample size
was very large, the heterogeneity of the study designs and modes of antibiotic delivery made it impossible to conduct a formal meta-
analysis. Interventions investigated included the utility of adding vancomycin and gentamycin to the irrigating solution compared with
standard balanced saline solution irrigation alone, use of intracameral cefuroxime with or without topical levofloxacin perioperatively,
periocular penicillin injections and topical chloramphenicol-sulfadimidine drops compared with topical antibiotics alone, and mode
of antibiotic delivery (subconjunctival versus retrobulbar injections; fixed versus separate instillation of gatifloxacin and prednisolone).
The risk of bias among studies was low to unclear due to information not being reported. We identified one ongoing study.
Two studies compared any antibiotic with no antibiotic. One study, which compared irrigation with antibiotics in balanced salt solution
(BSS) versus BSS alone, was not sufficiently powered to detect differences in endophthalmitis between groups (very low-certainty
evidence). One study found reduced risk of endophthalmitis when combining intracameral cefuroxime and topical levofloxacin (risk
ratio (RR) 0.14, 95%confidence interval (CI) 0.03 to 0.63; 8106 participants; high-certainty evidence) or using intracameral cefuroxime
alone (RR 0.21, CI 0.06 to 0.74; 8110 participants; high-certainty evidence) compared with placebo, and an uncertain effect when
using topical levofloxacin alone compared with placebo (RR 0.72, CI 0.32 to 1.61; 8103 participants; moderate-certainty evidence).
Two studies found reduced risk of endophthalmitis when combining antibiotic injections during surgery and topical antibiotics
comparedwith topical antibiotics alone (risk ratio (RR) 0.33, 95%confidence interval (CI) 0.12 to 0.92 (periocular penicillin and topical
chloramphenicol-sulfadimidine; 6618 participants; moderate-certainty evidence); and RR 0.20, 95% CI 0.04 to 0.91 (intracameral
cefuroxime and topical levofloxacin; 8101 participants; high-certainty evidence)).
One study, which compared fixed versus separate instillation of gatifloxacin and prednisolone, was not sufficiently powered to detect
differences in endophthalmitis between groups (very low-certainty evidence). Another study found no evidence of a difference in
endophthalmitis when comparing subconjunctival versus retrobulbar antibiotic injections (RR 0.85, 95% CI 0.55 to 1.32; 77,015
participants; moderate-certainty evidence).
Two studies reported any visual acuity outcome; one study, which compared fixed versus separate instillation of gatifloxacin and
prednisolone, reported only that mean visual acuity was the same for both groups at 20 days postoperation. In the other study, the
difference in the proportion of eyes with final visual acuity greater than 20/40 following endophthalmitis between groups receiving
intracameral cefuroxime with or without topical levofloxacin compared with no intracameral cefuroxime was uncertain (RR 0.69, 95%
CI 0.22 to 2.11; 29 participants; moderate-certainty evidence).
Only one study reported adverse events (1 of 129 eyes had pupillary membrane in front of the intraocular lens and 8 eyes showed
posterior capsule opacity). No study reported outcomes related to quality of life or economic outcomes.
Authors’ conclusions
Multiple measures for preventing endophthalmitis following cataract surgery have been studied. High-certainty evidence shows that
injection with cefuroxime with or without topical levofloxacin lowers the chance of endophthalmitis after surgery, and there is mod-
erate-certainty evidence to suggest that using antibiotic eye drops in addition to antibiotic injection probably lowers the chance of
endophthalmitis compared with using injections or eye drops alone. Clinical trials with rare outcomes require very large sample sizes
and are quite costly to conduct; thus, it is unlikely that many additional clinical trials will be conducted to evaluate currently available
prophylaxis. Practitioners should rely on current evidence to make informed decisions regarding prophylaxis choices.
P L A I N L A N G U A G E S U M M A R Y
Antibiotics at the time of cataract surgery to prevent bacterial infection of the eye
What is the aim of this review?
The aim of this Cochrane Review was to find out if using antibiotics at the time of cataract surgery can prevent bacterial infection of
the eye (endophthalmitis) after cataract surgery. Cochrane researchers collected and analyzed all relevant studies to answer this question
and found five studies.
2Perioperative antibiotics for prevention of acute endophthalmitis after cataract surgery (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Key messages
There is a very small chance of endophthalmitis after cataract surgery. Antibiotics injected into the eye during surgery lower this small
chance of infection (high-certainty evidence). Antibiotic injection and antibiotic eye drops given together probably lower the chance
of infection compared with using either injection alone or eye drops alone. Information on adverse effects was not provided in most
studies.
What was studied in this review?
Endophthalmitis is a rare, but potentially serious, complication of cataract surgery that may lead to blindness. It is caused by bacteria
that enter the eye during surgery or in the first few days after surgery. There are many ways to stop infection during and after surgery,
such as using antibiotics at the time of surgery. There are several different types of antibiotic that can be used, and these may be used in
different ways (either by injection into the eye, or infusion into the blood, or eye drops) or at different times (before, during, or after
surgery).
What are the main results of the review?
Cochrane researchers found five relevant studies. Two studies were conducted in Pakistan, one study in several European countries, one
study in Brazil, and one study in Turkey. These studies all looked at different treatments: one study compared four different treatments
- antibiotic injection combined with antibiotic eye drops versus antibiotic injection alone versus antibiotic eye drops alone versus
placebo eye drops; one study compared combined antibiotic injection and antibiotic eye drops versus antibiotic eye drops alone; one
study compared combined antibiotics and steroids versus antibiotics and steroid given individually; one study compared two different
locations for the antibiotic eye injection; one study compared adding antibiotics to the sterile fluid used during surgery versus not
adding antibiotics to this fluid.
The review shows that:
• Antibiotic injection in the eye (cefuroxime) at the end of surgery lowers the chance of endophthalmitis after surgery (high-certainty
evidence).
• Using antibiotic eye drops (either levofloxacin or chloramphenicol) in addition to antibiotic injection (either cefuroxime or penicillin)
probably lowers the chance of endophthalmitis compared with using injections or eye drops alone (moderate certainty evidence).
• It is very uncertain whether adding antibiotic to the sterile irrigating fluid used during cataract surgery lowers the chance of endoph-
thalmitis (very low-certainty evidence).
• It is very uncertain if using antibiotics and steroids individually or in combination makes a difference to the chance of developing
endophthalmitis (very low-certainty evidence).
How up to date is this review?
Cochrane researchers searched for studies that had been published up to December 2016.
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S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
Perioperative antibiotics for prevention of endophthalmitis after cataract surgery
Population: part icipants undergoing cataract surgery
Settings: eye hospital or clinic
Outcome: risk of endophthalm it is af ter surgery
Perioperative prophylaxis versus no prophylaxis
Study ID No. eyes and par-
ticipants
Follow-up Comparison
(intervention vs
comparator)
Risk of endophthalmitis by study group RR (95% CI)
Treatment vs control
Certainty of the ev-
idence
(GRADE)
Presumed cases* Proven cases* * Presumed cases* Proven cases* *
Sobaci 2003 644 eyes of 640
part icipants
6 weeks Treatment:
BSS with ant ibi-
ot ics (vancomycin
20 mg/ mL and gen-
tamicin 8 mg/ mL)
Not reported 0/ 322 (0%) eyes Not reported 0.20 (0.01 to 4.15) ⊕©©©
Very low1,2
Control: BSS-only
irrigat ing infusion
f luid
Not reported 2/ 322 (0.62%) eyes
ESCRS 2007 16,603 eyes of 16,
603 part icipants
6 weeks Treatment 1: com-
bined intracameral
ce-
furoxime and topi-
cal levof loxacin
2/ 4052 (0.05%)
eyes
1/ 4052 (0.02%)
eyes
0.14 (0.03 to 0.63) 0.10 (0.01 to 0.78) ⊕⊕⊕⊕
High
Treatment 2: intra-
cameral cefurox-
ime 0.9%
3/ 4056 (0.07%)
eyes
2/ 4056 (0.05%)
eyes
0.21 (0.06 to 0.74) 0.20 (0.04 to 0.91) ⊕⊕⊕⊕
High
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Treatment 3: topi-
cal levof loxacin 0.
5%
10/ 4049 (0.25%)
eyes
7/ 4049 (0.17%)
eyes
0.72 (0.32 to 1.61) 0.70 (0.27 to 1.84) ⊕⊕⊕©
M oderate3
Control: placebo
drops
14/ 4054 (0.35%)
eyes
10/ 4054 (0.25%)
eyes
Comparisons of combinations of antibiotics with specific antibiotics
Study ID No. eyes and par-
ticipants
Follow-up Interventions Risk of endophthalmitis by study group RR (95% CI)
Treatment 1 vs treatment 2
Certainty of the ev-
idence
(GRADE)
Presumed cases* Proven cases* * Presumed cases* Proven cases* *
Christy 1979 6618 eyes of 6618
part icipants
1 week Treatment 1: com-
bined prophylaxis
(topical regimen
+ periocular peni-
cill in at the t ime of
surgery)
5/ 3309 (0.15%)
eyes
Not reported 0.33 (0.12 to 0.92) Not reported ⊕⊕⊕©
M oderate4
Treatment 2: topi-
cal regimen alone
(chloramphenicol-
sulfadim idine)
15/ 3309 (0.45%)
eyes
Not reported
ESCRS 2007 16,603 eyes of 16,
603 part icipants
6 weeks Treatment 1: com-
bined intracameral
ce-
furoxime and topi-
cal levof loxacin
2/ 4052 (0.05%)
eyes
1/ 4052 (0.02%)
eyes
Treatment 1 vs
treatment 2: 0.67
(0.11 to 3.99)
Treatment 1 vs
treatment 2: 0.50
(0.05 to 5.52)
⊕⊕⊕©
M oderate3
Treatment 2: intra-
cameral cefurox-
ime 0.9%
3/ 4056 (0.07%)
eyes
2/ 4056 (0.05%)
eyes
Treatment 2 vs
treatment 3: 0.30
(0.08 to 1.09)
Treatment 2 vs
treatment 3: 0.29
(0.06 to 1.37)
⊕⊕⊕©
M oderate3
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Treatment 3: topi-
cal levof loxacin 0.
5%
10/ 4049 (0.25%)
eyes
7/ 4049 (0.17%)
eyes
Treatment 1 vs
treatment 3: 0.20
(0.04 to 0.91)
Treatment 1 vs
treatment 3: 0.14
(0.02 to 1.16)
⊕⊕⊕⊕
High
Mode of antibiotic delivery
Study ID No. eyes and pa-
tients
Follow-up Interventions Risk of endophthalmitis by study group RR (95% CI)
M ode 1 vs mode 2
Certainty of the ev-
idence
(GRADE)
Presumed cases* Proven cases* * Presumed cases* Proven cases* *
Christy 1986 77,015 eyes of 77,
015 part icipants
1 week M ode 1: Ante-
rior sub-Tenon in-
ject ions (subcon-
junct ival)
38/ 39,752 (0.10%)
eyes
Not reported 0.85 (0.55 to 1.32) Not reported ⊕⊕⊕©
M oderate4
M ode 2: Poste-
rior sub-Tenon in-
ject ions (retrobul-
bar)
42/ 37,263 (0.11%)
eyes
Not reported
Cunha 2013 108 eyes of 108
part icipants
3 weeks Treatment 1: f ixed
com-
binat ion of topical
gat if loxacin 0.3%
and prednisolone
acetate 1%
0/ 47 (0%) eyes Not reported 0.43 (0.02 to 10.
34)
Not reported ⊕©©©
Very low1,5
Treatment 2: in-
dividual inst illat ion
of topical gat i-
f loxacin 0.3% and
prednisolone ac-
etate 1%
1/ 61 (2%) eyes Not reported
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GRADE Working Group grades of evidence
High-certainty: Further research is very unlikely to change our conf idence in the est imate of ef fect.
M oderate-certainty: Further research is likely to have an important impact on our conf idence in the est imate of ef fect and may change the est imate.
Low-certainty: Further research is very likely to have an important impact on our conf idence in the est imate of ef fect and is likely to change the est imate.
Very low-certainty: We are very uncertain about the est imate.
BSS: balanced salt solut ion; CI: conf idence interval; RR: risk rat io.
* Presumed cases: includes both culture-proven and clinically diagnosed cases of postoperat ive endophthalm it is.
* * Proven cases: cases conf irmed by at least one of Gram stain, culture, or polymerase chain react ion (PCR)
1 Downgraded for imprecision (-2) as the study did not enroll a suf f icient number of part icipants to detect dif f erences between
groups.
2 Downgraded for high risk of attrit ion bias (-1) as the study authors excluded part icipants at the t ime of surgery based on the
surgeon’s discret ion (number excluded not reported).
3 Downgraded for imprecision (-1) as the conf idence interval of the ef fect est imate between groups was wide.
4 Downgraded for indirectness (-1) as the study was conducted more than 30 years ago and the techniques for cataract
surgery have since changed substant ially.
5 Downgraded for high risk of attrit ion bias (-1) as the study authors excluded part icipants who did not return for follow-up
(16% of study populat ion).
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B A C K G R O U N D
Description of the condition
Age-related cataract is a leading cause of reduced vision in
both high-income and low-income countries (Friedman 2004;
Resnikoff 2004). Surgery for cataract involves removal of the
opaque lens and replacement with an intraocular lens (IOL). In
the few cases where IOL implantation is not possible, contact
lenses and glasses are valid options for the correction of the re-
fractive error that results from being aphakic (without a lens). En-
dophthalmitis is a potentially vision-threatening complication of
cataract surgery. Endophthalmitis is a severe inflammation of the
anterior or posterior (or both) chambers of the eye and may be
sterile or associated with infection. It most commonly occurs as
a complication of cataract surgery, but also may occur following
other ocular procedures, trauma to the eye, metastatic systemic
infections, and systemic inflammatory disorders.
Epidemiology
Reported endophthalmitis rates vary substantially, with some in-
dividual centers reporting no endophthalmitis in a several-year
period (Galvis 2014; Monica 2005), while others report rates as
high as 1 in 200 or 300 surgeries (ESCRS 2007; Garcia-Arumi
2007). One systematic review that included studies from high-
income and low-income countries indicated a decreasing inci-
dence of endophthalmitis following cataract surgery until the early
1990s, followed by an increase in incidence (Taban 2005a). The
pooled estimate for incidence of endophthalmitis was 1.09 per
1000 surgeries from 1963 to 1999 and 2.65 per 1000 surgeries
from 2000 to 2003 (Taban 2005a). In addition, an analysis of
US Medicare data reported a 40% increase in the adjusted risk
of endophthalmitis comparing data from 1998 to 2001 against
1994 to 1997, with annual rates ranging from 1.79 to 2.47 cases
per 1000 surgeries (West 2005). An analysis of Medicare fee-for-
service cataract surgeries reported that rates declined to 1.32 per
1000 surgeries in 2003 and 1.11 per 1000 surgeries in 2004 (Keay
2012). Rates appear to have remained relatively consistent, with
two more recent Medicare analyses showing rates of 1.2 per 1000
surgeries (Coleman 2015; Du 2014). Other national-level data
have shown a decline, with Sweden’s reported rate dropping from
0.48 per 1000 surgeries in 2002 through 2004 to 0.29 per 1000
surgeries for 2005 through 2010 (Friling 2013), and Iran reports
an overall rate of 0.02% (Jabbarvand 2016). Furthermore, India
has recently reported a rate of 0.08% among patients not receiving
intracameral antibiotics and 0.02% among those receiving intra-
cameral antibiotics (Haripriya 2016).
Presentation and diagnosis
Endophthalmitis usually presents within a few days following
cataract surgery, and 80% of cases present within six weeks.
Presenting features include decreased visual acuity (VA), pain,
swelling and redness of the eyelids, redness of the conjunctiva,
haziness of the cornea due to edema, and increased cellularity of
fluid in the anterior chamber of the eye with or without hypopyon
(pus). Signs of infection and inflammation of the retina and vitre-
ous usually are observed during exam. Although endophthalmitis
is a rare infection, it often results in significant long-term mor-
bidity, even when treated appropriately. Approximately 50% of
people do not regain vision of 20/40 or better despite treatment
(Gower 2015; Lalwani 2008), and often nearly one-third have
acuity worse than 20/200 following treatment (Gower 2015; Ng
2005; Sheng 2011).
Description of the intervention
Several factors are thought to contribute to the incidence of en-
dophthalmitis following cataract surgery.One primary factor is the
type of incision used for surgery (Lundstrom 2007; Taban 2005a;
Taban 2005b). In addition, many research studies have focused
on the role of antibiotics used prophylactically to target ocular
surface flora. Examples of prophylactic measures include preoper-
ative lash-trimming and irrigation of the lacrimal drainage system
with antibiotics, antiseptic preparation of the operative site using
agents such as povidone iodine, and preoperative, intraoperative,
and postoperative administration of antibiotics. Perioperative an-
tibiotics may be administered through parenteral, topical, or in-
travitreal routes, using a variety of antibiotics. This review focuses
only on perioperative antibiotic use as a prophylactic measure.
How the intervention might work
The vast majority of culture-proven postoperative endophthalmi-
tis cases are caused by gram-positive bacteria, with most cases
caused by Staphylococcus epidermidis and other coagulase-negative
staphylococci, flora commonly found on the ocular surface (EVSG
1995; Mollan 2007; Ng 2005; Schimel 2013). Other gram-pos-
itive organisms and gram-negative agents are less frequently as-
sociated with acute endophthalmitis; however, some of the less
common gram-negative organisms are associated with the worst
visual outcomes. Streptococci are considered themost virulent and
have the worst outcomes (Barry 2009; Gower 2015; Miller 2004;
Simunovic 2012; Soriano 2006). The conjunctiva and eyelids are
the most common sources of infection. The bacteria from these
sites are presumably introduced into the anterior chamber through
the surgical incision. Endophthalmitis occurs when the intrinsic
immune defenses fail to eliminate the virulent bacterial inoculum.
To assist the inborn bactericidal processes of the eye, perioperative
antibiotics are used to decrease intraocular microbial contamina-
tion. Decreasing contamination can be accomplished in several
ways, depending on the route of drug administration. Topical an-
tibiotics directly penetrate the ocular surface to enter the aqueous
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humor of the eye (i.e. the fluid in the anterior chamber). Some
antibiotics administered orally achieve intraocular concentrations
via systemic delivery, while other antibiotics do not effectively pen-
etrate the eye. Intracameral antibiotic administration is the most
direct route of delivery to the site of potential infection.
Perioperative antibiotics eliminate etiologic organisms by either
bacteriostatic or bactericidal mechanisms. Bacteriostatic agents ar-
rest the growth and replication of bacteria found on the ocular
surface, eyelids, or those already iatrogenically introduced into the
aqueous humor. Thus, these drugs limit the spread of infection
while the body’s immune system eliminates the nonproliferating
pathogens. Bactericidal antibiotics kill the bacteria directly, de-
creasing the total concentration of viable microorganisms. Bac-
tericidal agents are more commonly used in ocular surgery as
they can achieve more rapid destruction of invading bacteria. Fre-
quently used perioperative antibiotics with bactericidal proper-
ties include fluoroquinolones, vancomycin, aminoglycosides, and
cephalosporins.
Why it is important to do this review
Cataract surgery is the most common operative procedure in the
aged population. While endophthalmitis is relatively rare, the fre-
quency of the procedure makes the absolute number of cases sig-
nificant enough to be a public health problem. In 2003 to 2004,
nearly 1.6 million cases of cataract surgery were performed annu-
ally in the US Medicare fee-for-service population alone (Schein
2012), and an estimated 10 million procedures were performed
worldwide annually in the 1990s (Foster 2001). Experts estimate
that the annual target for cataract surgery should be above 30 mil-
lion surgeries (Foster 2001). At that rate, and assuming an inci-
dence of one case per 1000 surgeries, 30,000 cases of postcataract
surgery endophthalmitis would occur annually, with about 10,000
leading to blindness in the operated eye. Visual recovery following
acute postoperative endophthalmitis remains poor across differ-
ent clinical settings, despite advances in treatment (Lalitha 2005;
Miller 2005; Ng 2005; Sheng 2011). The extensive use of surgery
to provide better vision for people with cataracts across the world
calls for adoption of evidence-based methods to prevent acute
endophthalmitis. This systematic review update aims to identify
the current evidence to facilitate the adoption of evidence-based
practices for prophylaxis of acute endophthalmitis after cataract
surgery.
O B J E C T I V E S
To evaluate the effects of perioperative antibiotic prophylaxis for
endophthalmitis following cataract surgery comparedwith no pro-
phylaxis or other form of prophylaxis.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We included randomized controlled trials (RCTs). We employed
no date or language restrictions.
Types of participants
We included trials enrolling adults undergoing cataract surgery
with any procedure for lens opacities due to any origin.
Types of interventions
We included trials evaluating preoperative antibiotics, intraopera-
tive (intracameral, subconjunctival, or systemic), or postoperative
antibiotic prophylaxis for acute endophthalmitis. Comparisons of
interest included:
• any prophylaxis versus no prophylaxis;
• preoperative versus postoperative or intraoperative
prophylaxis or combinations;
• specific antibiotics used in included trials;
• mode of perioperative antibiotic delivery.
We excluded studies that evaluated antiseptic preoperative prepa-
ration using agents such as povidone iodine. In addition, excluded
studies that evaluated antibiotics for treating acute endophthalmi-
tis after cataract surgery.
We excluded studies with less than one week of follow-up after
surgery.
Types of outcome measures
Primary outcomes
• Endophthalmitis: both presumed and culture-proven
endophthalmitis within six weeks after cataract surgery. Our
primary analysis was based on six-week outcomes; however, we
also evaluated data from weeks one to four.
• Visual acuity (VA) measured either as a mean logMAR
score or as the number of participants with best-corrected VA
better than 20/40 and those worse than 20/200 at the different
follow-up times. Whenever multiple VA measures were available,
we used acuity at six weeks after diagnosis as the primary
outcome measure.
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Secondary outcomes
• Adverse effects: specific adverse effects of interest were
postoperative bacterial keratitis, antibiotic resistance if
documented, allergy and anaphylaxis. We also summarized other
adverse effects as reported in included trials.
• Quality of life measures.
• Economic data
Search methods for identification of studies
Electronic searches
We searched CENTRAL (which contains the Cochrane Eyes
and Vision Trials Register) (2016, Issue 12), Ovid MEDLINE,
Epub Ahead of Print, In-Process & Other Non-Indexed Cita-
tions, OvidMEDLINE Daily (January 1946 to December 2016),
Embase (January 1980 to December 2016), Latin American and
Caribbean Health Sciences Literature Database (LILACS) (1982
to December 2016),the ISRCTN registry (www.isrctn.com/
editAdvancedSearch), ClinicalTrials.gov (www.clinicaltrials.gov),
and the World Health Organization (WHO) International Clini-
cal Trials Registry Platform (ICTRP) (www.who.int/ictrp/search/
en). We used no date or language restrictions in the electronic
searches for trials. We last searched the electronic databases on 6
December 2016.
See: Appendices for details of search strategies for CENTRAL
(Appendix 1),MEDLINE (Appendix 2), EMBASE (Appendix 3),
LILACS (Appendix 4), the ISRCTN (Appendix 5), ClinicalTri-
als.gov (Appendix 6) and the ICTRP (Appendix 7).
Searching other resources
We searched for additional studies that cited any included refer-
ences using the Science Citation Index Expanded database (Web
of Science).
Data collection and analysis
Selection of studies
Two review authors independently reviewed the titles and abstracts
resulting from the literature searches according to the inclusion
criteria. We classified abstracts as ’definitely exclude’, ’unsure’ or
’definitely include’. We obtained the full-text for articles in the
’unsure’ category and reassessed them for inclusion. A third re-
view author resolved any disagreement between the two review
authors. Studies excluded after full-text review are listed in the
Characteristics of excluded studies table along with the reasons for
exclusion.
Data extraction and management
We developed data extraction forms to collect data from the in-
cluded studies. We tested the forms using a few studies prior to
extracting data for all included studies. Two review authors inde-
pendently extracted study characteristics, methods, and outcomes
data, and assessed risk of bias for all included studies. The two
review authors compared data extraction forms and resolved dis-
crepancies between them by discussion. One review author en-
tered the data into Review Manager 5 (RevMan 2014), and a sec-
ond review author checked the entered data for accuracy.
Assessment of risk of bias in included studies
Two review authors independently assessed the included studies
for risk of bias according to guidelines set out in Chapter 8 of the
CochraneHandbook for Systematic Reviews of Interventions (Higgins
2011), and a third review author resolved any discrepancies. For
each domain related to systematic biases, we made judgments of
’low risk of bias’, ’unclear risk of bias’, or ’high risk of bias’ for each
included study.
• Selection bias: adequate sequence generation and allocation
concealment. Examples of adequate sequence generation
included using computerized randomization or random number
lists. Methods such as centralized randomization and
sequentially numbered, sealed, opaque envelopes provided
adequate allocation concealment.
• Performance bias: masking of study participants and
personnel. For studies in which masking was not done or not
possible (e.g. surgeons administering subconjunctival versus
retrobulbar injections), we considered whether the person
knowing the treatment assignment could have influenced the
treatment effects.
• Detection bias: masking of outcome assessors.
• Attrition bias: incomplete outcome data. We assessed
whether follow-up rates and reasons for losses to follow-up were
similar in the comparison groups and whether all participants
were analyzed in the group to which they were randomized.
• Reporting bias: selective outcome reporting. Studies that
reported results for all study outcomes described in the methods
section of the included papers were considered to have low risks
of reporting bias.
• Other sources of bias: other potential sources of bias that
were considered included, but were not limited to, funding
source, study design, and imbalance in baseline characteristics.
A third review author resolved any disagreement in assessments by
the two review authors. In the event of missing or unclear data,
we contacted the primary investigators for additional information.
We allowed six weeks for a response; failing that, we used the
information as available in identified reports.
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Measures of treatment effect
For individual studies, we presented dichotomous outcomes as
risk ratios (RR) with 95% confidence intervals (CI). We did not
conduct meta-analyses as part of this review.
Unit of analysis issues
The unit of analysis was the individual (one eye per participant) in
four studies (Christy 1979; Christy 1986; Cunha 2013; ESCRS
2007). In the Sobaci 2003 study, both eyes of 4/640 (less than
1%) participants were included in the analysis; for the remaining
636 participants, only one eye was included.
Dealing with missing data
In the event of missing or unclear data, we contacted the primary
investigators for additional information. We allowed six weeks for
a response; failing that, we used the information as available in
identified reports. We analyzed outcome data using the available
data, assuming data were missing at random. We did not perform
missing data statistics as the proportion of missing data was low
(less than 1% of included participants) in most studies.
Assessment of heterogeneity
Weassessed clinical heterogeneity using qualitative information on
trial methodology, participant characteristics, interventions com-
pared, routes of administration of prophylacticmeasures, duration
of follow-up, and losses to follow-up. We performed no statistical
tests for heterogeneity.
Assessment of reporting biases
Typically, funnel plots are used to examine reporting biases when
10 or more studies contribute to a given outcome. In this review
with only five included studies and no meta-analysis, funnel plots
were not appropriate.
Data synthesis
Because of the small number and heterogeneity of the included
studies, we described data for each study narratively.
Subgroup analysis and investigation of heterogeneity
We performed no subgroup analyses.
Sensitivity analysis
We conducted no sensitivity analyses, given the small number of
included studies.
’Summary of findings’ table
We prepared a ’Summary of findings’ table including relative and
absolute effects for the outcome of endophthalmitis for all com-
parisons. We assessed the certainty of evidence for all outcomes in
this review using the GRADE classification system (GRADEpro
2014).
R E S U L T S
Description of studies
Results of the search
Electronic literature searches as of 25 October 2012 identified
491 potentially relevant titles and abstracts for this review (Gower
2013). After duplicate independent abstract review, 12 records
were assessed at the full-text level, of which four were excluded
and eight were included in the review. The eight records reported
four studies. A review of references that cited the included studies
and the reference lists of included studies identified one additional
record that was excluded after full-text assessment.
An updated search as of December 2016 identified 157 new
records (Figure 1). The Cochrane Information Specialist removed
50 duplicate records and we screened the remaining 107 reports.
We rejected 101 records after reading the abstracts and obtained
the full-text reports of six references for further assessment. We
identified one new study which met the inclusion criteria (Cunha
2013), and one ongoing trial (NCT02770729).We excluded four
studies (Carron 2013; Cetinkaya 2015; Li 2015; Pérez-Canales
2015; see Characteristics of excluded studies table for details).
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Figure 1. Study flow diagram.
Included studies
We include fiveRCTs in this review (seeCharacteristics of included
studies table). The studies enrolled 101,005 adults undergoing
cataract surgery. The five studies varied widely in the approaches
and prophylactic measures examined.
The first two studies were conducted at cataract surgery camps
in northern Pakistan where intracapsular cataract extraction was
performed, and participants were followed postoperatively for one
week (Christy 1979; Christy 1986). Endophthalmitis diagnosis
was made based on clinical signs. Although intracapsular cataract
extraction is rarely performed in the 21st century, and hence the
relevance of these studies for contemporary consideration is re-
duced, the role of prophylactic antibiotics remains relevant to con-
temporary practice, and surgical camps remain amainstay inmany
low-income countries. Thus, these studies are described briefly.
Christy 1979 compared combined chloramphenicol-sulfadimi-
dine drops and periocular injection of 500,000 units of ben-
zyl penicillin with chloramphenicol-sulfadimidine drops alone in
6618 people/eyes. All participants were providedwith a single dose
of antibiotic ointment on the day prior to surgery and immedi-
ately after surgery; sulfadimidine 5% drops were instilled on sub-
sequent days.
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Christy 1986 compared subconjunctival versus retrobulbar injec-
tion of antibiotics in 77,015 people/eyes. All participants received
five applications of a sulfadimidine-chloramphenicol solution in
the 20 hours before surgery. In both studies, participants were fol-
lowed for one week after surgery and evaluated for endophthalmi-
tis based on clinical signs.
The three more recent studies employed phacoemulsification.
Sobaci 2003 was conducted in Turkey and compared antibiotics
(vancomycin and gentamycin) in balanced salt solution (BSS) ir-
rigating infusion fluid with BSS-only irrigating infusion fluid in
644 eyes of 640 participants. All were treated with ofloxacin and
diclofenac sodium four times on the day prior to surgery. Povi-
done iodine was utilized for antisepsis at the time of surgery and
a solution of ofloxacin, dexamethasone, and indomethacin was
given postoperatively. Follow-up was for six weeks postoperation.
Since the incidence of endophthalmitis following cataract surgery
is low (the study authors of Sobaci 2003 reported the rate of post-
operative endophthalmitis at their institution was 0.109%) and
because only 644 eyes were included in the study (with less than
one eye expected to be affected), the study lacked sufficient power
to detect valid differences between treatments.
ESCRS 2007 conducted at multiple sites throughout Europe and
Turkey, implemented a two-by-two factorial design to evaluate in-
tracameral cefuroxime injected at the end of surgery and topical
levofloxacin given immediately preoperatively (within one hour of
surgery) and up to 15 minutes following surgery in 16,603 partic-
ipants. In a factorial design studying two drugs or procedures that
are expected to act independently, treatment arms were allocated
such that both drugs could be evaluated alone and in combina-
tion. In ESCRS 2007, the two interventions studied were intra-
cameral cefuroxime and topical levofloxacin. One group received
only intracameral cefuroxime, one group received only topical lev-
ofloxacin, one group received both intracameral cefuroxime and
topical levofloxacin, and one group received neither intervention.
Povidone iodine was used for antisepsis at the time of surgery and
topical levofloxacin was given to all participants starting themorn-
ing after surgery. Follow-up was for six weeks postoperation.
In Cunha 2013, all participants underwent phacoemulsification
with IOL implantation. The use of a fixed combination of gat-
ifloxacin 0.3% and prednisolone acetate 1% (i.e. both drugs in
a single bottle) was compared with the administration of gati-
floxacin 0.3% alone and prednisolone acetate 1% alone. Partic-
ipants instilled the drops beginning one day before the cataract
surgery until 15 days postoperation. Although the study authors
reported endophthalmitis as an adverse outcome, the study was
not designed to assess differences in endophthalmitis rates between
intervention groups. Further, with only 129 enrolled participants,
the study did not have sufficient power to detect valid differences
between treatment groups.
Excluded studies
We excluded nine studies overall: six were not RCTs and three
did not evaluate the risk of endophthalmitis (see Characteristics
of excluded studies table).
Risk of bias in included studies
Allocation
Although all the included studies were RCTs, only ESCRS 2007
reported sufficient detail to be judged as having adequate sequence
generation and allocation concealment (Figure 2). ESCRS 2007
used computerized randomization for sequence generation and
coded droppers to conceal treatment assignments. Cunha 2013 re-
ported using an adequate sequence generationmethod, but did not
report whether the allocation sequence was concealed. We judged
the remaining three studies as having unclear sequence generation
and allocation concealment. Christy 1986 reported that a deck of
cardsmarked with the treatment assignments was used to random-
ize participants to treatment groups. The treatment administered
to the participant was determined by the card that was on the top
of the deck at the time of surgery; however, it was not clear whether
the markings on the cards were concealed prior to surgery. Sobaci
2003 reported that participants were randomly allocated to treat-
ment group according to the scheduled day of surgery. However,
it is unclear whether the treatment assignment was stratified by
the day of surgery, or whether the day’s treatment assignment was
revealed at the start of the operative day and alternated from day
to day. Christy 1979 did not report any information regarding
allocation other than that the study was randomized.
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Figure 2. Risk of bias summary: review authors’ judgements about each risk of bias item for each included
study.
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Masking (performance bias and detection bias)
One study reported masking all study participants and person-
nel by distributing identical bottles with masked labels (Cunha
2013). ESCRS 2007 masked participants and clinicians by us-
ing coded droppers with either active or placebo drops. Partici-
pants and physicians were not masked for the injections since no
sham injections were performed for those not receiving the in-
tracameral cefuroxime injection. Participants and physicians who
were present during the surgery were masked to the drops, and
other clinical partners were masked to both drops and injections
throughout the study. It was unclear whether the physicians who
were present during the surgery or their clinical partners were as-
sessing the outcomes for the study. One other study was reported
to be masked, but details of who was masked and how masking
was accomplished were not reported (Christy 1979). We assessed
these three studies as having low risks of performance and detec-
tion bias, since masking was reported and we would not expect the
diagnosis of endophthalmitis to be affected if masking was bro-
ken. The two remaining included studies did not report masking
(Christy 1986; Sobaci 2003).
Incomplete outcome data
Risk of bias due to incomplete outcome data was low in three
studies and high in two studies (Figure 2). In Sobaci 2003, judged
as having a high risk of bias, eyes of participants for which the
surgical procedure was modified according to physician discretion
during surgery were excluded from the study. Reasons for modi-
fying the protocol included administering subconjunctival antibi-
otics and adding a suture. The number of excluded participants
was not reported. In Cunha 2013, more than 15% of participants
were not included in the analyses, most due to missing the follow-
up visit. Christy 1979 and Christy 1986 reported no exclusions
or losses to follow-up; however, the study authors noted that data
were limited to early postoperative infections occurring one week
after surgery, since most participants lived too far away for follow-
up visits once discharged. The studies undertook no bacteriologic
confirmation of infection. Although ESCRS 2007 reported fol-
lowing intent-to-treat analyses, 324 (2%) participants who were
lost to follow-up and 68 (0.4%) participants who did not undergo
the planned surgery or withdrew consent (timing of withdrawal
not specified) were excluded from the analyses.
Selective reporting
Risk of selective reporting bias in these studies was low. All studies
employed commonly usedmethods for reporting endophthalmitis
cases. Two studies reported results for suspected cases without
bacteriological confirmation (Christy 1979; Christy 1986). Sobaci
2003 reported results for bacteriologically confirmed cases, and
ESCRS 2007 reported results for all suspected cases as well as for
bacteriologically confirmed cases. Cunha 2013 did not report how
endophthalmitis was diagnosed.
Christy 1986 used two types of antibiotics for injections, deter-
mined by the surgeon doing the operation. The study authors re-
ported that infection rates were similar between the two types of
antibiotics and the two surgeons, but did not report infection rates
for treatment groups (anterior versus posterior injections) sepa-
rately by type of antibiotic.
Other potential sources of bias
Wedid not identify other potential sources of bias for the included
studies.
Effects of interventions
See: Summary of findings for the main comparison
Perioperative antibiotics for prevention of endophthalmitis after
cataract surgery
The results of the five studies are described individually below.
Interventions differed between them. Given the heterogeneity of
study designs and modes of antibiotic delivery, we decided against
conducting meta-analyses. We describe outcome data and present
a summary of postoperative endophthalmitis for all comparisons
in Summary of findings for the main comparison.
The primary outcome for four studies was postoperative en-
dophthalmitis following cataract surgery; the fifth study investi-
gated prophylaxis and control of inflammation following cataract
surgerywith endophthalmitis reported as an adverse outcome.The
two earliest studies relied on clinical diagnosis of endophthalmitis
(Christy 1979; Christy 1986). Sobaci 2003 reported results for
bacteriologically confirmed cases only, ESCRS 2007 reported re-
sults for all suspected cases as well as the subset of bacteriologically
confirmed cases, and Cunha 2013 did not report how endoph-
thalmitis was defined.
Perioperative prophylaxis versus no prophylaxis
Irrigation with antibiotics in balanced salt solution versus
balanced salt solution alone
In Sobaci 2003, at six weeks 0/322 (0%) eyes that received van-
comycin and gentamycin in BSS irrigating infusion fluid had post-
operative endophthalmitis compared with 2/322 (0.62%) eyes
that received BSS-only irrigating infusion fluid. The between-
group difference reflected the small number of cases that the study
was not powered to detect a difference (RR 0.20, 95% CI 0.01 to
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4.15). We assessed the certainty of evidence for this outcome as
very low, downgrading for imprecision of the effect estimate and
high risk of attrition bias in the study.
Intracameral with or without topical antibiotics versus no
antibiotics
In ESCRS 2007, the risk of clinically diagnosed (presumed) post-
operative endophthalmitis at six weeks was significantly reduced
for eyes that received intracameral cefuroxime injections, with or
without topical levofloxacin, compared with no prophylaxis (nei-
ther injection nor topical levofloxacin) (RR 0.14, 95% CI 0.03
to 0.63 with topical levofloxacin; RR 0.21, 95% CI 0.06 to 0.74
without topical drops). There were similar results when analyz-
ing culture-proven cases of postoperative endophthalmitis. We as-
sessed the certainty of evidence for these outcomes as high, finding
no reason to downgrade the assessment.
The effect of topical levofloxacin alone compared with no prophy-
laxis to reduce the risk of postoperative endophthalmitis was less
certain (RR 0.72, 95% CI 0.32 to 1.61 for presumed cases; RR
0.70, 95% CI 0.27 to 1.84 for culture-proven cases). We assessed
the certainty of evidence for this outcome as moderate, downgrad-
ing for imprecision.
Comparisons of combinations of antibiotics with
specific antibiotics
Chloramphenicol-sulfadimidine drops with versus without
periocular penicillin
In the Christy 1979 study of chloramphenicol-sulfadimidine
drops with or without periocular penicillin injection, 5/3309
(0.15%) eyes that received combined prophylaxis (drops and in-
jection at the time of surgery) had postoperative endophthalmitis
at one week, compared with 15/3309 (0.45%) eyes that received
the topical regimen alone (RR 0.33, 95% CI 0.12 to 0.92). We
assessed the certainty of evidence for this outcome as moderate,
downgrading for indirectness as the study was conducted in the
mid-to-late 1970s and the techniques for cataract surgery have
since changed substantially.
Intracameral and topical antibiotics versus either antibiotic
alone
In ESCRS 2007, a risk reduction was observed for eyes treated
with combined intracameral cefuroxime and topical levofloxacin
compared with eyes treated with topical levofloxacin alone for
presumed cases of postoperative endophthalmitis (RR 0.20, 95%
CI 0.04 to 0.91), but this difference was less precise for culture-
proven cases (RR 0.14, 95% CI 0.02 to 1.16). We assessed the
certainty of evidence for this outcome as high, finding no reason
to downgrade the assessment.
When comparing combined intracameral cefuroxime and topical
levofloxacin with eyes treated with intracameral cefuroxime alone,
the difference of postoperative endophthalmitis was unclear (RR
0.67, 95% CI 0.11 to 3.99 for presumed cases; RR 0.50, 95% CI
0.05 to 5.52 for proven cases).We assessed the certainty of evidence
for this outcome as moderate, downgrading for imprecision.
Additionally, the head-to-head comparison of intracameral ce-
furoxime alone comparedwith topical levofloxacin alone suggested
that intracameral cefuroxime may perform better or as good as
topical levofloxacin for preventing postoperative endophthalmitis
(RR 0.30, 95% CI 0.08 to 1.09 for presumed cases; RR 0.29,
95% CI 0.06 to 1.37 for proven cases). We assessed the certainty
of evidence for this outcome as moderate, downgrading for im-
precision.
Mode of antibiotic delivery
Subconjunctival versus retrobulbar antibiotic injection
In Christy 1986, at one week after surgery, 38/39,752 (0.10%)
eyes receiving subconjunctival injection had presumed postopera-
tive endophthalmitis, compared with 42/37,263 (0.11%) eyes re-
ceiving retrobulbar antibiotic injection. The risk of postoperative
endophthalmitis was similar between groups (RR 0.85, 95% CI
0.55 to 1.32). We assessed the certainty of evidence for this out-
come as moderate, downgrading for indirectness as the techniques
of the cataract surgery used in the study were different compared
with current cataract surgery methods.
Fixed combination versus individual instillation of
topical antibiotic and corticosteroid
Cunha 2013 compared fixed combination versus individual instil-
lation of gatifloxacin 0.3% and prednisolone acetate 1%. None
of 47 eyes that received the fixed combination had postoperative
endophthalmitis compared with 1/61 (2%) eyes that received the
individual drops up to 20 days postoperation (RR 0.43, 95% CI
0.02 to 10.34).Due to the small number of participants and events
in the study, the analysis was not powered to detect a difference
between groups. We assessed the certainty of evidence for this out-
come as very low, downgrading for imprecision of the effect esti-
mate and high risk of attrition bias in the study.
Visual acuity
Only one study reported VA outcomes for postoperative endoph-
thalmitis (ESCRS 2007). Cunha 2013 reported that mean VA was
the same for both groups at baseline (0.3 logMAR) and 20 days
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postoperation (0.1 logMAR). No other study reported VA out-
comes.
ESCRS 2007 presented outcomes in a combined manner for both
intracameral cefuroxime injection groups compared to topical lev-
ofloxacin or no prophylaxis groups combined (Table 1).
Proportion of eyes with final visual acuity greater than 20/40
following endophthalmitis
Among the five presumed cases of postoperative endophthalmitis
who received intracameral cefuroxime injections, two (40%) had
final VA better than 20/40. Among the 24 presumed cases of
postoperative endophthalmitis who did not receive intracameral
cefuroxime injections, 14 (58.3%) had final VA better than 20/
40. The difference between antibiotic injection and no injection
groups was uncertain (RR 0.69, 95% CI 0.22 to 2.11). There
were similar results for culture-proven cases between antibiotic
injection (1/3 (33.3%) eyes) and no injection (10/17 (58.1%)
eyes) groups (RR 0.57, 95% CI 0.11 to 2.95). We assessed the
certainty of evidence for this outcome as moderate, downgrading
for imprecision.
Proportion of eyes with final visual acuity less than 20/200
following endophthalmitis
Among the five presumed cases of postoperative endophthalmitis
who received intracameral cefuroxime injections, none had final
VA worse than 20/200. Among the 24 presumed cases of post-
operative endophthalmitis who did not receive intracameral ce-
furoxime injections, four (16.7%) had final VA worse than 20/
200. This difference between injection and no-injection groups
was very imprecise (RR 0.46, 95% CI 0.03 to 7.48). There were
similar results for proven cases between the injection (0/3 (0%)
eyes) and no injection (4/17 (23.5%) eyes) groups (RR 0.50, 95%
CI 0.03 to 7.54). We assessed the certainty of evidence for this
outcome as moderate, downgrading for imprecision.
Adverse effects
Cunha 2013 was the only study to report adverse events.
Cunha 2013 did not report information specific to postoperative
bacterial keratitis, antibiotic resistance, allergy, or anaphylaxis. At
20 days postoperation, the one eye in the individual drops group
with endophthalmitis had pupillary membrane in front of the
IOL. Three eyes (6%) in the fixed combination group compared
with five eyes (8%) in the individual drops group showed posterior
capsule opacity. The study authors reported no cases of hypopyon
or IOL pigmentation and no statistically significant difference be-
tween group with respect to central or incisional corneal edema.
Quality of life
No study reported outcomes related to quality of life measures.
Economic outcomes
No study reported outcomes related to economic data.
D I S C U S S I O N
Summary of main results
The studies included in this review were too heterogeneous for us
to perform a meta-analysis. The five included studies tested three
modes of delivery for antibiotic prophylaxis measures: intraocu-
lar injection, topical drops, and antibiotics in the irrigating solu-
tion. The two studies that reported statistically significant differ-
ences among treatment arms both included antibiotic injection
during surgery (one intraocular and the other periocular), and the
treatment arms that included ocular injection had the lowest rates
of endophthalmitis, ranging from 0.14 to 1.5 endophthalmitis
cases per 1000 surgeries (Christy 1979; ESCRS 2007).Within the
ESCRS 2007 study, the primary results paper combined the two
intracameral injection groups for comparison against placebo and
reported a 4.9-fold increased risk of endophthalmitis when not
using intracameral injection, which can be translated to an 80%
decrease in endophthalmitis risk when using intracameral injec-
tion.
In this review, we calculated RRs and CIs for multiple compar-
isons within ESCRS 2007 using the data provided in the study
reports; we compared both intracameral injection of cefuroxime
and topical drops individually to placebo and to the combined
regimen. Both the combined prophylaxis and the intracameral in-
jection alone showed a reduced risk of both presumed and culture-
proven endophthalmitis compared with no prophylaxis. Compar-
ison of the combined regimen against topical drops alone showed
a reduction in risk for presumed cases, but not for culture-proven
cases only.
Sobaci 2003 compared antibiotics in the irrigating solution against
BSS alone, and reported a lower endophthalmitis rate (0/322 eyes
versus 2/322 eyes up to six weeks after surgery) in the treatment
arm that included antibiotics (RR 0.20, 95% CI 0.01 to 4.15). If
the study were adequately powered, this difference would trans-
late to an 80% reduction in endophthalmitis. However, the over-
all sample size for this study was quite small (644 eyes) for a rare
outcome like endophthalmitis, limiting the ability to evaluate sta-
tistical significance, as noted by the wide CIs (95% CI 0.01 to
4.15). Similarly, Cunha 2013 enrolled 129 participants, with only
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108 participants analyzed at 20 days postoperation, resulting in a
high degree of imprecision among outcomes.
Christy 1986 investigated the mode of delivery of antibiotics in-
jected during surgery, and found no significant difference between
subconjunctival and retrobulbar injection. The rates of endoph-
thalmitis (1.0 to 1.1 per 1000 surgeries) in that study were compa-
rable to endophthalmitis rates reported in the 21st century, even
though surgery was performed in surgical camp settings in a de-
veloping country and that intracapsular surgery was performed.
However, it is notable that this study only followed participants
for one week, so some cases likely were missed.
Overall completeness and applicability of
evidence
The five studies included 101,005 adults and 132 total endoph-
thalmitis cases. While the overall sample size was quite large, the
heterogeneity of the study settings, designs, and modes of antibi-
otic delivery made it impossible to combine the studies and make
direct comparisons. Two studies were conducted in the late 1970s
and early 1980s. Cataract surgery practice has changed substan-
tially since that time, making the results of these studies less appli-
cable today. Povidone iodine is now used routinely in most coun-
tries and is a proven measure for reducing intraocular infection
(Speaker 1991). In addition, wound construction is quite differ-
ent. In the 1970s and early 1980s large (180°) incisions were used
routinely. Today, even in the most remote centers, much smaller
incisions are employed. Small-incision manual surgery is now the
procedure of choice in the majority of surgical camp settings in
low-income countries.Despite these changes in surgical technique,
Christy 1979 suggested that adding periocular penicillin injection
substantially reduced the risk of endophthalmitis.
Among the five studies, the ESCRS 2007 results are most applica-
ble to 21st century surgical practice, as it used contemporary sur-
gical techniques and study drugs that are readily available in Eu-
rope. Its design allowed for examination of both topical and intra-
cameral antibiotics, and included a sample size sufficient to yield
statistically significant results. Thus, among the studies reviewed,
it provided the firmest evidence upon which to recommend a pro-
phylactic regimen in these settings, and suggested that intracam-
eral antibiotic injection is useful in reducing the risk of postcataract
surgery endophthalmitis. However, the choice of antibiotic re-
mains a question for many physicians. Since the publication of
ESCRS2007, uptake of intracameral cefuroxime has variedwidely.
In the UK, approximately 50% of providers reported intracam-
eral antibiotic use (Gore 2009). A retrospective analysis of billing
codes in France suggested that the use of intracameral antibiotics
increased from 0.60% to 80% between 2005 and 2014, likely due
to the ESCRS recommendations (Creuzot-Garcher 2016). Up-
take has been more limited in the US. Results of the 2011 Ameri-
can Society of Cataract and Refractive Surgery (ASCRS) member
survey showed less than 20% of physicians utilizing intracameral
antibiotics (Leaming 2012; Vazirani 2013). By the ASCRS 2014
survey, 50% of US physicians reported use of intracameral antibi-
otics (Chang 2015); however, this percentage remains well below
the rates in Europe, Australia and New Zealand (Behndig 2015;
Meyer 2016; Schwartz 2016), and US physicians continue to ex-
press concerns about the lack of a commercially available prepara-
tion. In the US, incorporating intracameral antibiotics into stan-
dard prophylaxis practice appears to be related to surgeon volume
(Chang 2008), and increased surgeon volume has been reported to
be associated with reduced risk of postoperative endophthalmitis
(Keay 2012). In both the US and UK, physicians not using intra-
cameral antibiotics cite concerns regarding dilution errors and risk
of contamination when compounding the drugs for doses needed
for ocular injection (Gore 2009; Leaming 2012). These factors
are important to consider when evaluating the applicability of the
current evidence. Further discussion on this issue is provided be-
low in the Agreements and disagreements with other studies or
reviews section.
Quality of the evidence
The five studies included in this review varied substantially in the
prophylaxis measures that they compared and the way data were
reported. Two of these studies, Christy 1979 and Christy 1986,
were conducted over 30 years ago, when standards for randomiza-
tion and reporting in clinical trials were less stringent and less well-
defined. To the credit of the Christy team, they provided detailed
information on both the operative procedure and the follow-up
procedures. All five studies randomized participants, but random
sequence generation and allocation concealment were described
fully only in ESCRS 2007. Hence, we cannot judge whether some
selection bias may have occurred in the other studies.
Masking of the intervention was not complete in most of these
studies. In some, the person in charge of outcome assessment was
unaware of the randomization and did not actively participate in
the surgery visits. These studies may be less prone to bias than
those in which the examiner was present at all times and was aware
of the treatment assignment.
Because of differences in the interventions used and outcomes as-
sessed among studies, we performed no meta-analysis. Overall,
one study provided moderate- to high-certainty evidence (ESCRS
2007); two studies, which were downgraded for indirectness, pro-
vided moderate-certainty evidence (Christy 1979; Christy 1986);
and two studies, which were downgraded for high risk of attri-
tion bias and imprecision, provided very low-certainty evidence
(Cunha 2013; Sobaci 2003).
Potential biases in the review process
Tominimize bias with regard to selecting studies for this review, we
devised a highly sensitive search strategy to identify relevant stud-
18Perioperative antibiotics for prevention of acute endophthalmitis after cataract surgery (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
ies from the published literature. We also searched other sources
such as the reference lists of included studies, the Science Citation
Index, and clinical trial registries. We imposed no date or language
restrictions.
Two review authors independently performed major steps in the
review process to minimize bias and errors when screening studies
for inclusion, recording study characteristics, extracting quantita-
tive data, and assessing risks of bias. The review team included
clinicians, researchers, and methodologists.
Agreements and disagreements with other
studies or reviews
The rare nature of endophthalmitis makes RCTs difficult to con-
duct, because of the very large sample sizes needed to make statis-
tically valid comparisons. Thus, few trials have been conducted,
and all that we are aware of are included here.Worldwide, numer-
ous single-center retrospective analyses have been conducted to
examine whether changes in practice patterns resulted in reduced
endophthalmitis rates. Several studies have reported reduced rates
of endophthalmitis following adoption of intracameral or sub-
conjunctival antibiotics (Beselga 2014; Garat 2009; Garcia-Saenz
2010;Montan 2002;Myneni 2013; Packer 2011; Shorstein 2013).
The antibiotic of choice has varied across studies of intracam-
eral injections, with moxifloxacin, vancomycin, and cefuroxime
all showing a reduction compared with no antibiotic injection
(Packer 2011). Most notably, numerous studies have investigated
the benefit of intracameral cefuroxime in light of the ESCRS study
and increased availability of the antibiotic in Europe. Data from
Sweden have shown extremely low rates of postoperative endoph-
thalmitis (0.029%) in the presence of intracameral cefuroxime
(Friling 2013). In Portugal, a center found that endophthalmitis
decreased from 0.26% to 0.0% after introduction of the ESCRS
protocol and use of intracameral cefuroxime (Beselga 2014). Sev-
eral other studies also have reported declines in endophthalmitis.
Across these studies, the general consensus has been that intra-
cameral antibiotic use reduces the risk of endophthalmitis, which
provides further support to the ESCRS 2007 study findings.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
This systematic review underscores the broad scope of prophylaxis
regimens considered to be of potential use in preventing endoph-
thalmitis following cataract surgery. Among the included studies,
the mode of antibiotic administration ranged widely from topi-
cal administration preoperatively to intraocular injections during
surgery. Given our decision not to conduct a meta-analysis of the
accumulated data, we are unable to report a direct comparison of
the effectiveness of these prophylactic measures. However, among
the individual studies evaluated, ESCRS 2007 provides the best
evidence for antibiotic prophylaxis against postcataract surgery
endophthalmitis. Clinical trials of this magnitude are costly and
take many years to conduct. Hence, decisions currently need to
be made based on the available evidence, with the possibility of
conducting future trials as new and improved prophylactic treat-
ments become available (antibiotics or otherwise).
ESCRS 2007 demonstrated the efficacy of using intracameral an-
tibiotics for reducing endophthalmitis. However, the antibiotic of
choicemay differ based on the clinical setting.Concerns of toxicity,
contamination, and other problems associated with compound-
ing and diluting remain with the use of cefuroxime (Chang 2015;
Delyfer 2011; Olavi 2012). US physicians indicate they may in-
crease their use of intracameral antibiotics if a single-dose vial were
commercially available (Chang 2015). Hence, the American So-
ciety of Cataract and Refractive Surgeons (ASCRS) has called for
the pharmaceutical industry and US Food and Drug Administra-
tion to prioritize development and approval of single-dose intra-
cameral antibiotics (Braga-Mele 2014; Chang 2015). One report
of ocular toxicity in a cluster of people following a dilution error
highlights the need for clinicians to remain vigilant in monitor-
ing preparation of intracameral antibiotics for use during surgery.
Resistance of endophthalmitis-causing organisms to moxifloxacin
appears to be increasing (Schimel 2013). In determining whether
to use intracameral injections and if so which antibiotic to use,
individual surgical centers should evaluate the risks and benefits
associated with the various available intracameral antibiotics and
the resources available for ensuring appropriate dilution and steril-
ity based on their setting (Olavi 2012).
Implications for research
This review highlights the limited amount of randomized con-
trolled trial data available for evaluating measures used to prevent
endophthalmitis following cataract surgery. Intraocular antibiotics
have been used for decades, with multiple studies conducted in
surgical camp settings in low-income countries. However, spec-
ulation remains over which antibiotics to use and what mode of
intraocular delivery is best.
Since the mid-2000s, a great deal of attention has been placed on
the value of adding an intracameral injection to the perioperative
regimen, and the findings of ESCRS 2007 support the effective-
ness of this practice. Several case reports and other retrospective
analyses have examined a variety of antibiotics for use in intra-
cameral injection at the close of cataract surgery (Packer 2011). To
date, however, the ESCRS 2007 study provides the only prospec-
tive clinical trial evidence for the use of intracameral antibiotics.
The reluctance of many physicians to utilize intracameral injec-
tions with currently available antibiotic preparations highlights
the need for the development of commercially available single-
use vials of antibiotics for intracameral injection. A single-use vial
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of cefuroxime, which requires only reconstitution and not dilu-
tion, was approved in Europe in 2012 (Thea Laboratories; Keating
2013). Numerous studies in Europe have reported increases in
the use of intracameral antibiotics and corresponding decreases in
rates of endophthalmitis following the increased use of cefurox-
ime (Barreau 2012; Beselga 2014; Daien 2016; Haripriya 2016;
Jabbarvand 2016). Surveys should be conducted in one to two
years to determine whether increased utilization of intracameral
antibiotics leads to increased antibiotic resistance or other ocular
complications, or both. Additionally, single-use vials of antibiotics
for intracameral use are needed in the US and other countries.
Some ophthalmologists currently utilizemoxifloxacin (Alcon) top-
ical drops for intracameral injection without dilution. Given that
the coverage spectrum of moxifloxacin is somewhat broader than
that of cefuroxime and available for use without dilution, it would
be of interest to research the comparative effectiveness of these two
drugs. However, such a study would require a sample size of over
100,000 participants, making it unlikely that it will ever be con-
ducted. On a longer view, new approaches to instilling antibiotics
into the anterior chamber are needed. Sustained drug-delivery de-
vices provide one example of an area ripe for additional research.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Christy 1979
Methods Study design: randomized controlled trial
Exclusions and loss to follow-up: none reported
Study follow-up: 1 week
Participants Setting: cataract surgery camp at Christian Hospital, Taxila, Pakistan
Enrollment: 6618 people undergoing cataract surgery
Age: not reported
Gender: not reported
Inclusion criteria: normal intraocular pressure; patent lacrimal drainage system
Exclusion criteria: active signs of ocular infection or inflammation
Interventions Intervention 1: topical regimen alone (chloramphenicol-sulfadimidine drops)
Intervention 2: combined prophylaxis (topical regimen + periocular penicillin during
surgery)
General: all surgeries were performed by 1 surgeon; surgical technique, postoperative
treatment, and follow-up were identical for both groups
Preoperative treatment: on the day prior to surgery, all participants’ faces were washed
with soap and water, eyelashes were clipped, and antibiotic ointment was applied to the
conjunctival sac. At the time of surgery, procaine 2% and retrobulbar blocks (lidocaine
2 mL of 2% with hyaluronidase 6 units/mL) were administered, participants’ eyelids
and surrounding face washed with sterile water, a lid speculum was inserted, and the
conjunctival sac irrigated with sterile water
Surgical technique: the surgeon used intracapsular cataract extraction procedure and
did not rescrub hands between cases or use gloves. All instruments were sterilized with
a speed autoclave. Operative technique included a 180° von Graefe knife incision; 1
peripheral iridectomy; 1 to 3 virgin silk corneoscleral sutures placed after the iridectomy
but before the lens extraction and forceps delivery of the lens. After the operation, 1 drop
of medication (pilocarpine 4%, polymyxin B sulfate 5000 IU/mL, neomycin sulfate 2.
5 mg/mL, and hydrocortisone acetate 5 mg/mL) was placed in the conjunctival sac and
a sterile pad placed over the eye
Postoperative treatment: eyes were examined and dressed daily. Antibiotic ointment
was instilled on the first day and on subsequent days a drop of sulfadimidine 5% and 1
drop of atropine 1%were instilled. Participants without complications were hospitalized
for 1 week
Outcomes Primary outcome: risk of clinical postoperative endophthalmitis within 1 week after
surgery; diagnosis was determined by slit lamp evaluation showing significant inflam-
mation in the anterior chamber; no bacterial cultures were taken
Unit of analysis: the participant (1 eye per person)
Notes Study dates: March to November 1977
Funding source: not reported
Publication language: English
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Christy 1979 (Continued)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Method of randomization was not re-
ported.
Allocation concealment (selection bias) Unclear risk Allocation concealment was not reported.
Masking of participants (performance bias) Low risk Although the study was reported to be
masked, details of masking or the use of
placebo were not reported
Masking of physicians and clinical care
providers (performance bias)
Low risk Although the study was reported to be
masked, details of masking or the use of
placebo were not reported
Masking of outcome assessment (detection
bias)
Low risk Although the study was reported to be
masked, details of masking were not re-
ported
Incomplete outcome data (attrition bias)
All outcomes
Low risk No exclusions or loss to follow-up were re-
ported; however, the study authors noted
that datawere limited to early postoperative
infections occurring 1 week after surgery
since most participants lived too far away
for follow-up visits once discharged
Selective reporting (reporting bias) Low risk Results were reported for the primary out-
come.
Other bias Low risk No other potential sources of bias identi-
fied.
Christy 1986
Methods Study design: randomized controlled trial
Exclusions and loss to follow-up: none reported
Study follow-up: 1 week
Participants Setting: cataract surgery camp at Christian Hospital, Taxila, Pakistan
Enrolment: 77,015 people undergoing cataract surgery
Age: not reported
Gender: not reported
Inclusion criteria: adults having nonimplant intracapsular cataract extractions
Exclusion criteria: people receiving intraocular lenses and children with congenital or
juvenile cataracts
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Christy 1986 (Continued)
Interventions Intervention 1: anterior sub-Tenon injections (subconjunctival); given beside the limbus
exactly subconjunctival or beneath the anterior part of Tenon’s capsule
Intervention 2:posterior sub-Tenon injections (retrobulbar); givenbeside the eye behind
the equator of the globe
General: 2 types of antibiotics were used for the injections: benzyl penicillin 500,000
units/0.5 mL or ampicillin 200 mg/0.5 mL
Preoperative treatment: all participants received 5 applications of 1 drop of sulfadimi-
dine 10% and chloramphenicol 0.5% solution between the first preoperative examina-
tion and surgery (about a 13- to 22-hour period)
Surgical technique: the surgeons used intracapsular cataract extraction and did not
rescrub hands between cases or use gloves. Surgeons were careful not to touch any needle,
suture, or part of any instrument that would come into contact with the participants’
eyes. Operations were performed quickly to keep the eye open for only 3 to 4 minutes.
Most operations included a 180° von Graefe knife incision; 1 peripheral iridectomy;
3 to 5 virgin silk sutures placed after the incision but before the lens extraction; and
intracapsular lens extraction performed with a simplified efficient cryoprobe
Outcomes Primary outcome: risk of clinical postoperative endophthalmitis 1 week after surgery;
diagnosis was determined by slit lamp evaluation showing significant inflammation in
the anterior chamber, no bacterial cultures were taken
Unit of analysis: the participant (1 eye per person)
Notes Study dates: January 1979 to June 1985
Funding source: not reported
Publication language: English
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk A deck of marked cards was used to ran-
domize participants to treatment groups
Allocation concealment (selection bias) Unclear risk A deck of marked cards was shuffled daily
and the top card at the time of surgery was
used to allocate participants to treatment
group. It is unclear whether the marks were
concealed (face-down) prior to allocation
or whether the study personnel could pre-
view the order of cards prior to allocation
Masking of participants (performance bias) Unclear risk Masking of participants was not reported.
Masking of physicians and clinical care
providers (performance bias)
Unclear risk Surgeons could not be masked to the inter-
ventions.
Masking of outcome assessment (detection
bias)
Unclear risk Masking of outcome assessors was not re-
ported.
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Christy 1986 (Continued)
Incomplete outcome data (attrition bias)
All outcomes
Low risk No exclusions or loss to follow-up were re-
ported; however, follow-up was only for 1
week after surgery
Selective reporting (reporting bias) Unclear risk 2 types of antibiotics were used for the in-
jections depending on the surgeon doing
the operation. The study authors reported
that infection rates were similar between
the 2 types of antibiotics and the 2 sur-
geons, but did not report infection rates by
treatment group (anterior vs posterior in-
jections) separately by type of antibiotic
Other bias Low risk No other potential sources of bias identi-
fied.
Cunha 2013
Methods Study design: randomized controlled trial
Exclusions and loss to follow-up: 21 (16%) participants were excluded; 20 because
they missed a scheduled follow-up visit and 1 due to ocular trauma requiring another
surgery
Study follow-up: 20 days
Participants Setting:Hospital of theMedical School of the University of São Paulo, São Paulo, Brazil
Enrolment: 129 people undergoing cataract surgery
Age: group 1: 71 ± 10 years (range 44 to 88); group 2: 71 ± 10 years (range 41 to 88)
Gender: 35/108 (32%) men and 73/108 (68%) women
Inclusion criteria: participants undergoing phacoemulsification and intraocular lens
implantation
Exclusion criteria: “history of uveitis or chronic ocular inflammation, pseudoexfoliation
syndrome, history of ocular trauma, uncontrolled diabetes, pregnant andnursingwomen,
allergy or sensitivity to any component of the medications, serious systemic diseases and
perioperative complications, such as anterior capsule rupture and vitreous loss.”
Interventions Intervention 1: fixed combination of gatifloxacin 0.3% and prednisolone acetate 1%
(Zypred, Allergan)
Intervention 2: individual instillation of gatifloxacin 0.3% and prednisolone acetate 1%
(Zypred and Predfort)
General: each participant received 2 bottles; drops instilled every 6 hours 1 day prior to
surgery to 15 days postoperation
Preoperative treatment: not reported
Surgical technique: the surgeons performed phacoemulsification and intraocular lens
implantation using the “phaco chop technique” under topical anesthesia
Outcomes Outcomes assessed: best-corrected visual acuity, tolerability (pain, photophobia, burn-
ing sensation, itching, foreign body sensation), signs of ocular inflammation (redness,
edema, tearing, discharge), conjunctival hyperemia, central and incisional corneal edema,
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Cunha 2013 (Continued)
anterior chamber cells, intraocular pressure, presence of hypopyon, posterior capsule
opacity, pigments or membrane in front of the intraocular lens, compliance, and adverse
events; no bacterial cultures were taken
Participants were seen on days 1, 7, 15, and 20
Unit of analysis: the participant (1 eye per person)
Notes Study dates: not reported
Funding source: not reported, but drugs were provided by Allergan Laboratories, Inc
Publication language: English
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “Patients were randomly assigned using the
Research Randomizer software (site: www.
randomizer.org); the value 1 was assigned
to patients enrolled in Group I, and the
value 2 was assigned to patients enrolled in
Group II.”
Allocation concealment (selection bias) Unclear risk Method of allocation concealment not re-
ported.
Masking of participants (performance bias) Low risk “The group assignment was masked from
all patients and investigators. Each patient
was given two identical bottles labeled ac-
cording to their group assignment. All bot-
tles were opaque and patients were in-
structed to apply one drop from each bottle
in the operated eye every 6 h with a 5-min
interval between drops, beginning one day
prior to the surgery until the 15th day.”
Masking of physicians and clinical care
providers (performance bias)
Low risk “The group assignment was masked from
all patients and investigators.”
Masking of outcome assessment (detection
bias)
Low risk “The group assignment was masked from
all patients and investigators.”
Incomplete outcome data (attrition bias)
All outcomes
High risk 21 (16%) participants were excluded from
the analyses.
Selective reporting (reporting bias) Low risk Results were reported for the outcomes as-
sessed.
Other bias Low risk No other potential sources of bias identi-
fied.
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ESCRS 2007
Methods Study design: randomized controlled trial
Exclusions and loss to follow-up: 324 (2%) participants were lost to follow-up; 68
participants were excluded because they did not undergo the planned surgery or they
withdrew consent
Study follow-up: 6 weeks
Participants Setting: 24 ophthalmology units in Austria, Belgium, Germany, Italy, Poland, Portugal,
Spain, Turkey, and the UK
Enrolment: 16,603 people undergoing phacoemulsification cataract surgery
Age: median for men was 73 years; for women was 75 years
Gender: 42% men and 58% women
Inclusion criteria: participants having routine cataract surgery at any study unit
Exclusion criteria: participants allergic to penicillins and cephalosporins, people in long-
term nursing homes, pregnant, or < 18 years; people severely at risk of infection (i.e.
atopic keratoconjunctivitis or active blepharitis)
Interventions Intervention 1: intracameral cefuroxime 0.9% (injected into the anterior chamber at
the end of surgery)
Intervention 2: topical levofloxacin 0.5% (instilled 1 drop 1 hour before surgery, 1 drop
30 minutes before surgery, and 3 more drops at 5-minute intervals immediately after
surgery)
Intervention 3: combined intracameral cefuroxime and topical levofloxacin
Intervention 4: placebo drops (no sham injection was given)
General: all study centers used povidone iodine 5% for antisepsis. Some centers addi-
tionally performed skin cleansing procedures; no detergents were used
Postoperative treatment: all participants were given topical levofloxacin 0.5% starting
the morning after surgery (approximately 18 hours after surgery) and 4 times daily for
6 days
Outcomes Primary outcomes (at 6 weeks’ postsurgery):
overall number of participants with presumed infectious postoperative endophthalmitis;
number of participants with infectious endophthalmitis as proven by at least 1 of Gram
stain, culture, or polymerase chain reaction
Secondary outcomes: other risk factors for increased susceptibility, such as clear corneal
incision or surgery during summermonths, or decreased risk, such as foldable intraocular
lenses inserted with sterile injector, etc
Unit of analysis: the participant (1 eye per person)
Notes Study dates: September 2003 to January 2006
Full study name: European Society of Cataract and Refractive Surgeons Study on the
Antibiotic Prophylaxis of Post-operative Endophthalmitis
Funding source: European Society of Cataract and Refractive Surgeons and Santen
GmbH, Germany
Publication language: English
Risk of bias
Bias Authors’ judgement Support for judgement
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ESCRS 2007 (Continued)
Random sequence generation (selection
bias)
Low risk 12-block computerized randomization
stratified by study center was used
Allocation concealment (selection bias) Low risk An electronic database was used to conceal
the treatment assignments for each partic-
ipant. Droppers were labeled with sequen-
tial subject IDs, which were entered into
the database at the time of surgery to de-
termine whether or not an injection should
be given. Treatment allocation codes were
held in a central randomization file
Masking of participants (performance bias) Low risk Partial masking of participants was done
with use of placebo drops. No sham injec-
tion was performed
Masking of physicians and clinical care
providers (performance bias)
Low risk Partial masking of physicians was done
by using identically labeled droppers. No
sham injection was performed
Masking of outcome assessment (detection
bias)
Low risk Physicians were partially masked and it was
reported that clinical partners were masked
throughout the study
Incomplete outcome data (attrition bias)
All outcomes
Low risk 324 (2%) participants who were lost to fol-
low-up and 68 (0.4%) participants who did
not undergo the planned surgery or with-
drew consent were excluded from the in-
tention-to-treat analyses
Selective reporting (reporting bias) Low risk Study outcomes were published in study
protocols, trial registrations and methods
papers prior to the study beginning. Re-
sults were reported for these primary and
secondary outcomes
Other bias Low risk Performed power calculations to enroll a
study size to detect a 4-fold reduction in
risk at 5% significance level
The study chairman, coordinator, clinical
partners, and data monitoring committee
were masked while the study was running
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Sobaci 2003
Methods Study design: randomized controlled trial
Exclusions and loss to follow-up: eyes for which the surgical procedure was modified
due to physician discretion at time of surgery were excluded from the study
Study follow-up: 6 weeks
Participants Setting: Gülhane Military Medical Academy and Medical School Hospital, Ankara,
Turkey
Enrolment: 644 eyes of 640 participants undergoing phacoemulsification cataract
surgery
Age: group 1: 64.2 ± 14.3 years (range 43 to 87); group 2: 61.2 ± 14.2 years (range 40
to 81)
Gender: not reported
Inclusion criteria: people scheduled to undergo phacoemulsification surgery
Exclusion criteria: people with previous history of immunosuppressive treatment, dia-
betes mellitus, ocular surgery, recent infection, or inflammation
Interventions Intervention 1: balanced salt solution-only irrigating infusion fluid (n = 322 eyes)
Intervention 2: balanced salt solution with antibiotics (vancomycin 20 mg/mL and
gentamicin 8 mg/mL; 322 eyes)
General: interventionswere given intraoperatively. Preoperative treatment, postoperative
treatment, and follow-up were identical for both groups
Preoperative treatment: 1-day course of topical ofloxacin 0.3% and diclofenac sodium
1 mg/mL 4 times a day; conjunctival smears were obtained just before povidone iodine
instillation at time of surgery
Surgical technique: phacoemulsification with a standard 3.2-mm clear corneal incision,
circular capsulotomy, and stop-chop technique followed by foldable hydrophobic acrylic
intraocular lens implantation; no sutures, subconjunctival antibiotics, or steroid injec-
tions were used
Postoperative treatment: eyes were treated with ofloxacin 0.3%, dexamethasone 1 mg/
mL, and indomethacin 0.1% drops with a 4-week tapering dose; participants were
discharged the day after surgery
Outcomes Primary outcomes:
risk of postoperative endophthalmitis;
aqueous humor contamination during phacoemulsification
Participants were seen on days 2, 5, 10, 15, 30, and 45
Unit of analysis: the eye (both eyes of 4 participants were included separately in the
analysis)
Notes Study dates: May 2000 to June 2002
Funding source: not reported
Publication language: English
The study authors reported the rate of postoperative endophthalmitis at their institution
was 0.109%, but only 644 eyes were included in the study
Risk of bias
Bias Authors’ judgement Support for judgement
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Sobaci 2003 (Continued)
Random sequence generation (selection
bias)
Unclear risk “Patients were randomly allocated to irri-
gating infusion fluid containing either bal-
anced salt solution (BSS)-only (group 1;
322 eyes of 320 patients) or BSS with an-
tibiotics (20 mg/ml vancomycin and 8 mg/
ml gentamicin) (group 2; 322 eyes of 320
patients), according to the scheduled day
of surgery, which was performed one after
another. (1:1).”
Allocation concealment (selection bias) Unclear risk Method of allocation concealment not re-
ported.
Masking of participants (performance bias) Unclear risk Masking of participants was not reported.
Masking of physicians and clinical care
providers (performance bias)
Unclear risk Masking of physicians was not reported.
Masking of outcome assessment (detection
bias)
Unclear risk Masking of outcome assessors was not re-
ported.
Incomplete outcome data (attrition bias)
All outcomes
High risk Eyes for which the surgical procedure was
modified due to physician discretion at
time of surgery were excluded from the
study.The number of excludedparticipants
was not reported
Selective reporting (reporting bias) Low risk Resultswere reported for both primary out-
comes.
Other bias Low risk No other potential sources of bias identi-
fied.
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Camesasca 2007 Endophthalmitiswas not anoutcome of the study: 2different postcataract surgery antibiotic/steroid therapeutic
combinations were compared in an intra-individual randomized controlled trial; 142 participants (284 eyes)
completed the 15-day study; the study outcomes were efficacy of treatment, frequency of complications, and
participant satisfaction
Carron 2013 Endophthalmitis was not an outcome of the study: topical ciprofloxacin 0.3% prior to cataract surgery was
compared with no antibiotics in a randomized controlled trial; 46 participants completed the 1-day study; the
study outcomes were the presence of bacteria in cultures taken the day prior to surgery, the morning of surgery,
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(Continued)
immediately before surgery, and at the end of surgery
Cetinkaya 2015 Not a randomized controlled trial: intracameral moxifloxacin was administered following standard cataract
surgery in some eyes, but not others; all participants received topical moxifloxacin for 1 week after surgery; data
were reviewed retrospectively and participants with intraoperative complications were excluded from analyses;
the study outcomes were postoperative best-corrected visual acuity, anterior chamber cell and flare, intraocular
pressure, and corneal edema
Kolker 1967 Not a randomized controlled trial: subconjunctival injections of antibiotics were administered following in-
traocular surgical procedures (including cataract, glaucoma, corneal transplant, pupillary membrane needling,
etc.) to alternate participants during the first phase of the study and to all participants subsequently; rates
for postoperative endophthalmitis were not reported separately for people with cataract who did not receive
antibiotics in the first phase of the study
Li 2015 Not a randomized controlled trial: topical neomycin/polymyxin-B was administered either 1 day or 1 hour
prior to cataract surgery; the authors reported the study as a prospective comparative case series; the study
outcomes were the presence of bacteria in cultures taken prior to the application of povidone-iodine before
surgery, after the application of povidone-iodine before surgery, and at the end of surgery
Maloof 2004 Not a randomized controlled trial: letter reporting changes made by a hospital following an increased rate
of endophthalmitis; changes included reorganizing the layout of the operating theater and administering
postoperative intracameral vancomycin
Paganelli 2009 Endophthalmitis was not an outcome of the study: an intraoperative injection of triamcinolone and ciproflo-
xacin in a controlled-release system (DuoCat) was compared with prednisolone and ciprofloxacin eye drops
after cataract surgery in a randomized controlled trial; 135 participants completed the 4-week study; the study
outcomes were postoperative anterior chamber cell and flare, intraocular pressure, lack of anti-inflammatory
response, and presence of infection
Peyman 1977 Not a randomized controlled trial: South Indian eye camps were sequentially divided into 3 groups of treatment
regimens: group 1: no prophylactic intracameral gentamicin was used, but oral and topical chloramphenicol
was given to all participants; group 2: female participants received prophylactic intracameral gentamicin, but
no chloramphenicol and male participants received oral and topical chloramphenicol, but no prophylactic
intracameral gentamicin; group 3: all participants received prophylactic intracameral gentamicin, but no chlo-
ramphenicol or any other antibiotic was given
Pérez-Canales 2015 Not a randomized controlled trial: intracameral injections of vancomycin versus cefuroxime were administered
at the end of cataract surgery; the authors reported the study as a prospective comparative case series; the study
outcomes were postoperative uncorrected and corrected distance visual acuity, refraction, anterior chamber cell
and flare, intraocular pressure, endothelial specular microscopy, and corneal edema and thickness
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Characteristics of ongoing studies [ordered by study ID]
NCT02770729
Trial name or title Use of Intracameral Moxifloxacin for the Prevention of Acute Endophthalmitis Following Cataract Surgery:
a Controlled and Randomized Clinical Trial
Methods Study design: parallel group, randomized controlled trial
Study follow-up: 8 weeks
Participants Setting: University of Campinas, Brazil
Estimated enrolment: 6000 eyes of 6000 participants undergoing cataract surgery
Inclusion criteria: people aged 50 to 100 years scheduled to undergo cataract surgery
Exclusion criteria: vulnerable people; people with allergy to moxifloxacin; people with ocular or periocular
infection, advanced glaucoma, or severe dry eye, or undergoing cataract surgery for traumatic cataract with
ocular perforation or other reasons (e.g. glaucoma filtering surgery, vitreoretinal surgery, and cornea surgery
Interventions Intervention 1: intracameral injection of moxifloxacin 0.5% at conclusion of cataract surgery
Intervention 2: no intracameral injection
Outcomes Primary outcome:
risk of postoperative endophthalmitis at 1 month
Secondary outcome:
endothelial cell count at 2 months
Starting date Study dates: May 2016 to May 2018
Contact information Principal investigator:
Mathias V Mélega, MD
University of Campinas, Brazil
Notes Study sponsor: University of Campinas, Brazil
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D A T A A N D A N A L Y S E S
This review has no analyses.
A D D I T I O N A L T A B L E S
Table 1. Visual acuity following endophthalmitis
Comparisons of specific antibiotics or combinations of antibiotics
Study ID Groups Proportion of eyes with
final VA > 20/40 fol-
lowing endophthalmi-
tis
RR (95% CI)
Group 1 vs group 2
Proportion of eyes with
final VA < 20/200 fol-
lowing endophthalmi-
tis
RR (95% CI)
Group 1 vs group 2
Presumed
cases*
Proven
cases**
Presumed
cases*
Proven
cases**
Presumed
cases*
Proven
cases**
Presumed
cases*
Proven
cases**
ESCRS
2007
Group 1:
intra-
cameral ce-
furox-
ime injec-
tion, with
or without
topical lev-
ofloxacin
drops
2/5 (40%)
eyes
1/3 (33.
3%) eyes
0.69 (0.22
to 2.11)
0.57 (0.11
to 2.95)
0/5 (0%)
eyes
0/3 (0%)
eyes
0.46 (0.03
to 7.48)
0.50 (0.03
to 7.54)
Group
2:no injec-
tion, with
or without
topical lev-
ofloxacin
drops
14/24 (58.
3%) eyes
10/17 (58.
1%) eyes
4/24 (16.
7%) eyes
4/17 (23.
5%) eyes
CI: confidence interval; final VA: visual acuity at time of last follow-up visit (range 3 weeks to 8 months); VA: visual acuity.
*Presumed cases: includes both culture-proven and clinically diagnosed cases of postoperative endophthalmitis.
**Proven cases: cases confirmed by at least one of Gram stain, culture, or polymerase chain reaction (PCR).
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A P P E N D I C E S
Appendix 1. CENTRAL search strategy
IDSearch
#1 MeSH descriptor: [Ophthalmologic Surgical Procedures] explode all trees
#2 MeSH descriptor: [Cataract] explode all trees
#3 MeSH descriptor: [Cataract Extraction] explode all trees
#4 cataract* near/3 extract* or aspirat* or operat* or remov* or surg* or excis* or implant*
#5 lens* near/3 extract* or aspirat* or operat* or remov* or surg* or excis* or implant*
#6 pha?oemulsif*
#7 lensectomy
#8 #1 or #2 or #3 or #4 or #5 or #6 or #7
#9 MeSH descriptor: [Endophthalmitis] explode all trees
#10 endophthalmitis
#11 ophthalmia
#12 #9 or #10 or #11
#13 MeSH descriptor: [Anti-Bacterial Agents] explode all trees
#14 antibiotic*
#15 bacteri*
#16 chloramphenicol*
#17 MeSH descriptor: [Ciprofloxacin] explode all trees
#18 ciprofloxacin*
#19 fusidic acid*
#20 gentamicin*
#21 levofloxacin*
#22 neomycin*
#23 ofloxacin*
#24 polymyxin* B
#25 cefazolin*
#26 MeSH descriptor: [Cefuroxime] explode all trees
#27 cefuroxime*
#28 moxifloxacin*
#29 norfloxacin*
#30 MeSH descriptor: [Vancomycin] explode all trees
#31 vancomycin*
#32#13 or #14 or #15 or #16 or #17 or #18 or #19 or #20 or #21 or #22 or #23 or #24 or #25 or #26 or #27 or #28 or #29 or #30 or
#31
#33 MeSH descriptor: [Antibiotic Prophylaxis] explode all trees
#34 prophyla*
#35 prevent*
#36 #33 or #34 or #35
#37 #8 and #12 and #32
#38 #36 and #37
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Appendix 2. MEDLINE Ovid search strategy
1. randomized controlled trial.pt.
2. (randomized or randomised).ab,ti.
3. placebo.ab,ti.
4. dt.fs.
5. randomly.ab,ti.
6. trial.ab,ti.
7. groups.ab,ti.
8. or/1-7
9. exp animals/
10. exp humans/
11. 9 not (9 and 10)
12. 8 not 11
13. exp ophthalmologic surgical procedure/
14. exp cataract/
15. exp cataract extraction/
16. ((cataract$ adj3 extract$) or aspirat$ or operat$ or remov$ or surg$ or excis$ or implant$).tw.
17. ((lens$ adj3 extract$) or aspirat$ or operat$ or remov$ or surg$ or excis$ or implant$).tw.
18. pha?oemulsif$.tw.
19. lensectomy.tw.
20. or/13-19
21. exp endophthalmitis/
22. endophthalmitis.tw.
23. ophthalmia.tw.
24. or/21-23
25. exp anti bacterial agents/
26. antibiotic$.tw.
27. bacteri$.tw.
28. chloramphenicol$.tw.
29. exp ciprofloxacin/
30. ciprofloxacin.tw.
31. (fusidic adj2 acid$).tw.
32. exp gentamicin/
33. gentamicin$.tw.
34. exp levofloxacin/
35. levofloxacin$.tw.
36. neomycin$.tw.
37. ofloxacin$.tw.
38. (polymyxin$ adj1 B).tw.
39. cefazolin$.tw.
40. exp cefuroxime/
41. cefuroxime$.tw.
42. moxifloxacin$.tw.
43. norfloxacin$.tw.
44. exp vancomycin/
45. vancomycin$.tw.
46. or/21-45
47. exp antibiotic prophylaxis/
48. prophyla$.tw.
49. prevent$.tw.
50. or/47-49
51. 20 and 24 and 46
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52. 50 and 51
53. 12 and 52
The search filter for trials at the beginning of the MEDLINE strategy is from the published paper by Glanville 2006.
Appendix 3. Embase Ovid search strategy
1. exp randomized controlled trial/
2. exp randomization/
3. exp double blind procedure/
4. exp single blind procedure/
5. random$.tw.
6. or/1-5
7. (animal or animal experiment).sh.
8. human.sh.
9. 7 and 8
10. 7 not 9
11. 6 not 10
12. exp clinical trial/
13. (clin$ adj3 trial$).tw.
14. ((singl$ or doubl$ or trebl$ or tripl$) adj3 (blind$ or mask$)).tw.
15. exp placebo/
16. placebo$.tw.
17. random$.tw.
18. exp experimental design/
19. exp crossover procedure/
20. exp control group/
21. exp latin square design/
22. or/12-21
23. 22 not 10
24. 23 not 11
25. exp comparative study/
26. exp evaluation/
27. exp prospective study/
28. (control$ or prospectiv$ or volunteer$).tw.
29. or/25-28
30. 29 not 10
31. 30 not (11 or 23)
32. 11 or 24 or 31
33. exp cataract/
34. exp cataract extraction/
35. ((cataract$ adj3 extract$) or aspirat$ or operat$ or remov$ or surg$ or excis$ or implant$).tw.
36. ((lens$ adj3 extract$) or aspirat$ or operat$ or remov$ or surg$ or excis$ or implant$).tw.
37. pha?oemulsif$.tw.
38. lensectomy.tw.
39. or/33-38
40. exp endophthalmitis/
41. endophthalmitis.tw.
42. ophthalmia.tw.
43. or/40-42
44. exp antiinfective agent/
45. antibiotic$.tw.
46. bacteri$.tw.
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47. chloramphenicol$.tw.
48. ciprofloxacin.tw.
49. (fusidic adj2 acid$).tw.
50. gentamicin$.tw.
51. levofloxacin$.tw.
52. neomycin$.tw.
53. ofloxacin$.tw.
54. (polymyxin$ adj1 B).tw.
55. cefazolin$.tw.
56. cefuroxime$.tw.
57. moxifloxacin$.tw.
58. norfloxacin$.tw.
59. vancomycin$.tw.
60. or/44-59
61. exp antibiotic prophylaxis/
62. prophyla$.tw.
63. prevent$.tw.
64. or/61-63
65. 39 and 43 and 60
66. 64 and 65
67. 32 and 66
Appendix 4. LILACS search strategy
cataract$ or phacoemulsification or IOL and endophthalmitis
Appendix 5. ISRCTN Trials search strategy
(cataract OR phacoemulsification OR IOL) AND endophthalmitis
Appendix 6. ClinicalTrials.gov search strategy
(cataract OR phacoemulsification OR IOL) AND endophthalmitis
Appendix 7. ICTRP search strategy
cataract AND endophthalmitis
WH A T ’ S N E W
Last assessed as up-to-date: 6 December 2016.
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Date Event Description
6 December 2016 New search has been performed Issue 2, 2017: searches updated
6 December 2016 New citation required but conclusions have not
changed
Issue 2, 2017: one new study added (Cunha 2013); one
ongoing trial identified (NCT02770729)
H I S T O R Y
Protocol first published: Issue 1, 2007
Review first published: Issue 7, 2013
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19 August 2008 Amended Converted to new review format.
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D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
We added methods for the assessment of the certainty of evidence and presentation of outcomes in a ’Summary of findings’ table
according to revised Cochrane standards.
I N D E X T E R M S
Medical Subject Headings (MeSH)
Acute Disease; Anti-Bacterial Agents [∗administration & dosage]; Cataract Extraction [∗adverse effects]; Endophthalmitis [∗prevention
& control]; Injections, Intraocular [methods]; Ophthalmic Solutions [administration & dosage]; Postoperative Complications
[∗prevention & control]; Randomized Controlled Trials as Topic; Therapeutic Irrigation [methods]; Visual Acuity
MeSH check words
Adult; Humans
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